Published: Fri, September 22, 2017
Economy | By Annette Adams

Highwater Wealth Management LLC Takes $264000 Position in Johnson & Johnson (JNJ)

Prudential Fincl Incorporated accumulated 4.96 million shares or 0.55% of the stock. This nets out to an increase of 2.64 million shares and is a bullish sign for JNJ. Johnson & Johnson now has $362.93 billion valuation. The stock declined 0.19% or $0.25 reaching $131.5 per share. About 17,837 shares traded.

Johnson & Johnson (NYSE:JNJ) institutional sentiment increased to 0.94 in Q4 2016. It has underperformed by 4.16% the S&P500. Ws Management Lllp sold 985,000 shares as Coeur Mng Inc (CDE)'s stock rose 6.31%. Cpcm has an ownership of 15,626 company stock worth at $1,946,000 following purchasing an extra 190 shares through out the quarter. The stock rose 0.23% or $0.14 reaching $61.36. About 30,661 shares traded. It has underperformed by 5.40% the S&P500.

Concert Wealth Management Inc, which manages about $1.87B and $103.01M US Long portfolio, upped its stake in Facebook Inc (NASDAQ:FB) by 2,174 shares to 2,474 shares, valued at $376,000 in 2017Q2, according to the filing. CIBC World Markets Inc. now owns 948,655 shares of the company's stock valued at $118,155,000 after acquiring an additional 500,662 shares during the period. Whole Foods Mkt Inc (Put) (NASDAQ:WFM) was raised too.

In the most updated research from a number of analysts on Wall Street, the company gets 9 Buys and 2 Sell among 21 analysts. Therefore 50% are positive. Coeur Mining had 33 analyst reports since August 6, 2015 according to SRatingsIntel. S&P Research has "Buy" rating and $120 target. Barclays Capital maintained the shares of PG in report on Thursday, October 29 with "Overweight" rating. The rating was initiated by UBS on Tuesday, September 22 with "Buy". Johnson & Johnson presently has an average rating of "Hold" and a consensus target price of $135.29. The stock has "Buy" rating by RBC Capital Markets on Wednesday, July 26. The company was maintained on Tuesday, June 14 by Jefferies. On Wednesday, August 19 the stock rating was upgraded by Moffett Nathanson to "Buy". The company was upgraded on Monday, October 3 by Deutsche Bank.

Short interest, or the number of a stock's tradable shares now being shorted, is another metric investors use to get a pulse on sentiment. Its down 0.03, from 0.86 in 2017Q1. Finally, Sumitomo Mitsui Trust Holdings Inc. increased its position in shares of Johnson & Johnson by 0.5% in the first quarter. Clearbridge Investments raised its stake in stocks of Johnson & Johnson by 3.4% in the 1st period. Groesbeck Investment Nj reported 2,200 shares stake. State Street Corporation has invested 0% in iPass Inc. Fisher Asset Management LLC increased its position in shares of Johnson & Johnson by 1.2% in the first quarter. The Switzerland-based Credit Suisse Ag has invested 0.01% in Coeur Mining Inc (NYSE:CDE). Estabrook Management has invested 0% of its portfolio in Johnson & Johnson (NYSE:JNJ). Nelson Van Denburg Campbell Wealth Mgmt Group Llc accumulated 0.87% or 16,228 shares. Great West Life Assurance Can reported 0% in Coeur Mining Inc (NYSE:CDE). Oppenheimer Asset Management Inc. purchased a new position in shares of Johnson & Johnson in the first quarter valued at about $65,598,000. 39,096 are owned by Natixis.

Among 22 analysts covering Johnson & Johnson (NYSE:JNJ), 10 have Buy rating, 5 Sell and 7 Hold. Laffer Invs reported 6,360 shares. Jacobs Levy Equity Management Inc invested in 0.02% or 22,030 shares. (NYSE:RT). 31,605 are held by Arizona State Retirement.

0 of these were buys and 2 were sells. Skoufalos Ioannis also sold $334,265 worth of Procter & Gamble Co (NYSE:PG) on Monday, May 22. Paulus Stoffels, Exec VP, Chief Scientific Off sold $13,672,413 worth of shares at an average price of $133.14 on July 24th. The business had revenue of $18.84 billion for the quarter, compared to analysts' expectations of $18.94 billion. The company reported $1.83 EPS for the quarter, topping analysts' consensus estimates of $1.79 by $0.04. This translates into $4.80 billion profit for JNJ giving the stock a 18.55 P/E. After posting $1.83 EPS for the previous quarter, Johnson & Johnson's analysts now forecast -2.19 % negative EPS growth.

Investors sentiment decreased to 1.01 in Q2 2017.

In other news, VP Dominic J. Caruso sold 82,591 shares of the firm's stock in a transaction dated Thursday, July 20th. 97 funds opened positions while 444 raised stakes. Hartford Inv reported 1.61% stake.

Johnson & Johnson (NYSE:JNJ) previously issued its periodic earnings reports on early Tue, Jul 18th. Hutchin Hill Cap Limited Partnership holds 0.15% in Johnson & Johnson (NYSE:JNJ) or 34,300 shares. Moreover, Td Mgmt Limited Co has 0.08% invested in Procter & Gamble Co (NYSE:PG) for 2,887 shares. (NASDAQ:IPAS). Art Advsrs Ltd Co holds 0% or 14,183 shares in its portfolio. Kessler Gru Limited Co reported 4.39% stake. Greenwood Assoc Lc, a South Carolina-based fund reported 57,166 shares. The Georgia-based Atlanta Cap Mngmt L L C has invested 0.22% in Johnson & Johnson (NYSE:JNJ).

Supplementing insider data with technical indicators can help an investor form a more complete view on the outlook for a stock. After a recent check, it is observed that the insiders for the firm now own 2.02% shares. Goldman Sachs Grp Inc stated it has 10.35M shares. Bridgeway Cap Management stated it has 1.07% of its portfolio in Johnson & Johnson (NYSE:JNJ).

Ratings analysis reveals 45% of Johnson & Johnson's analysts are positive. The firm earned "Hold" rating on Tuesday, March 15 by Jefferies.

Like this: